The Form Bio team, from L-R: co-CEO Andrew Busey; director of bioinformatics Brandi Cantarel; co-CEO Kent Wakeford; chief strategy officer Claire Aldridge; plus Colossal CEO Ben Lamm (Business Wire)
September 27, 2022 11:05 AM EDTUpdated 12:21 PM
Financing
Startups

George Church’s wool­ly mam­moth re­vival biotech Colos­sal spins out com­pu­ta­tion­al bio out­fit

Lei Lei Wu

News Reporter

Colos­sal Bio­sciences has a some­what lofty goal — re­vive the wool­ly mam­moth. When the biotech launched in 2021, its CEO Ben Lamm com­pared its mis­sion to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

Will CRISPR mat­ter?

FDA says Ozem­pic, We­govy short­age is over

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times